Karel Geboes

Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial

Paul Rutgeerts, Gert Van Assche, William J. Sandborn et al. · Gastroenterology · 2012 · 575 citations

Inflammation, Chronic Inflammatory Diseases, Anti-inflammatory +10

Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis

Filip J. Baert, Geert D’Haens, Marc Peeters et al. · Gastroenterology · 1999 · 467 citations

Inflammation, Chronic Inflammatory Diseases, Tumor Necrosis Factor +8

Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial

Paul Rutgeerts, Gert Van Assche, Séverine Vermeire et al. · Gastroenterology · 2005 · 418 citations · Full text

Gastroenterology, Placebo-controlled Trial, Disease Recurrence +6

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Ingrid Arijs, K. Li, Gary Toedter et al. · Gut · 2009 · 399 citations · Full text

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

Peter Suenaert, Veerle Bulteel, Liesbeth Lemmens et al. · The American Journal of Gastroenterology · 2002 · 386 citations